Alvogen and Lotus Launch the First Generic Equivalent to Revlimid(TM) Capsules in Selected European

PINE BROOK, New Jersey, February 13, 2019 /PRNewswire/ -- Global pharmaceutical company, Alvogen, today announced the launch of the first generic equivalent ... Lees verder

Bron:

ANP Pers support